Status:

ENROLLING_BY_INVITATION

Evaluation of Lymphatic Response to Physiotherapy in Patients With Swelling Associated With Superficial Venous Disease

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

Tactile Medical

Conditions:

Chronic Venous Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This study seeks to demonstrate the effect of advanced pneumatic compression in treatment naïve patients with CEAP C3 and C4 chronic venous disease. The main questions it aims to answer are: * Does l...

Eligibility Criteria

Inclusion

  • Participant \>18 years of age
  • Participant with an objective diagnosis of CEAP Class 3 or 4 superficial venous disease (superficial reflux time \>0.5 sec), with venous edema (revised VCSS score of 2 or 3 for edema).
  • Participant must provide informed consent
  • Participant is willing and able to fulfill study timeline
  • Participant is a candidate for APCD treatment per the FTP indications
  • Lymphatic dysfunction is observed, using NIRF-LI, in affected limb.

Exclusion

  • History of pelvic or lower extremity cancers
  • Systemic organ failure including heart failure
  • BMI \>35
  • Previous endovascular or open vascular interventions
  • Patients with known, or family history of, primary lymphedema
  • Prior use of advanced pneumatic compression device, or complete decongestive therapy (CDT) on the lower extremities
  • Peripheral arterial disease with ABI \<0.8
  • Participants with deep venous obstruction
  • Skin disease not related to CVD
  • Participants with iodine allergies including patients with shellfish allergy who may be allergic to iodine that may be in the ICG formulation
  • Females who are pregnant or breastfeeding
  • Females with the intent of becoming pregnant within 30 days after participation in final imaging session

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2026

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT07165340

Start Date

September 1 2025

End Date

August 1 2026

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Health Science Center at Houston/UTPhysicians

Houston, Texas, United States, 77030